Ovesco Endoscopy AG

Resect smarter – New tools and techniques from cap to snare Endoscopic resection continues to evolve. Join our upcoming webinar to explore different resection techniques and learn more about the practical application of selected Ovesco solutions. 📅 27 October 2026 🕐 6 PM CET Our clinical experts will share their experience and insights on: ▪️Cap-based techniques and the importance of continued innovation – Prof. Siegbert Faiss (Sana Klinikum Lichtenberg, Berlin, Germany) ▪️The RampCap: practical experience and potential applications – Prof. peter bauerfeind (Hirslanden Klinik St. Anna. Luzern, Switzerland) ▪️ AWC®duo in clinical practice: initial clinical findings and experience – Prof. Kunsch (Rems-Murr-Klinikum, Winnenden, Germany) ▪️All-In-One Snare Probe: applications and clinical case examples – Mingyan Cai, MD, PhD in Surgery (Endoscopy Center, Zhongshan Hospital of Fudan University, Shanghai China) Register now for free 👇

FTRD®neo is now available!* 😊🙌 Over the past few weeks, we gave you a glimpse of what’s new. Today, we’re proud to share the full picture. FTRD®neo, the next generation of endoscopic full-thickness resection, is built around a single ambition: peak performance in clip application. Discover what’s new: 👉 Clip application you can trust – the new ring design features elevations for reliable clip application. The blue color provides visual confirmation of successful deployment. 👉 Greater patient comfort right from the start – the rounded surface of the clip teeth edges enable smoother passage through the GI tract. 👉 Better control and smoother preparation – the redesigned handwheel provides more stability, enables easier access to the working channel, and allows for faster, more intuitive fixation thanks to a silicone strap. 👉 Seamless integration across endoscope brands – expanded compatibility of colonic FTRD®neo, which now fits outer diameters up to 14 mm. More reliable. More intuitive. More compatible. And built on a foundation you already trust: the same proven FTRD® principle backed by over 10 years of clinical experience, more than 140 published studies, and 65,000+ procedures worldwide. 🔍 Learn more at https://lnkd.in/eD3itxkC or contact us directly! *This content is intended exclusively for healthcare professionals. Please refer to the instructions for use and note country-specific approvals and indications.

Looking for evidence-based guidance in bleeding management? The new ESGE guideline recommends OTSC®neo as first-line monotherapy – backed by RCT data and acknowledged for its cost-effectiveness. Download your flyer to learn more about OTSC®neo.

When the situation becomes critical, you need a solution that works reliably. OTSC®neo delivers "one & done" hemostasis.

Acute situations leave no room for uncertainty. When standard methods reach their limits, stress levels rise. OTSC®neo offers a standardized, clinically proven solution. The clip provides reliable hemostasis and reduces the risk of re-bleeding. More control, less stress — when it matters most.

"Before: Uncertainty about costs. After: Proven cost-effectiveness with OTSC®neo."